Giedrimas Evaldas, Goldberger Jeffrey J
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, 251 East Huron Street, Feinberg 8-503E, Chicago, IL 60611, USA.
Future Cardiol. 2013 Jul;9(4):581-96. doi: 10.2217/fca.13.26.
The treatment of cardiac arrhythmias has evolved significantly over the last 30 years. Understanding of arrhythmia mechanisms has led to pharmacologic therapies, surgical interventions and the widely used percutaneous catheter ablation techniques. The focus of this review is centered on the current catheter ablation therapies available for supraventricular tachycardia. We will discuss current management strategies including challenges when considering catheter ablation therapy for management of supraventricular tachycardias: atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia utilizing an accessory pathway, atrial tachycardia and atrial flutter. Selected contemporary issues related to supraventricular tachycardia physiology, ablation approaches and ablation outcomes and complications will be discussed. Future goals for electrophysiologists are to continue to improve procedural safety and efficiency, while maintaining the impressive success rates that have been achieved.
在过去30年里,心律失常的治疗有了显著进展。对心律失常机制的认识催生了药物治疗、外科手术干预以及广泛应用的经皮导管消融技术。本综述的重点集中在目前可用于室上性心动过速的导管消融治疗。我们将讨论当前的管理策略,包括在考虑采用导管消融治疗室上性心动过速时所面临的挑战:房室结折返性心动过速、利用附加通路的房室折返性心动过速、房性心动过速和心房扑动。还将讨论与室上性心动过速生理学、消融方法、消融结果及并发症相关的一些当代问题。电生理学家未来的目标是在保持已取得的令人瞩目的成功率的同时,继续提高手术的安全性和效率。